BioSpace News Archive

Skanska has signed a contract with RWJBarnabas Health to build an ambulatory care cancer center in Livingston, New Jersey, USA.

Pharvaris, a clinical-stage company developing novel, oral bradykinin-B2-receptor antagonists to treat and prevent hereditary angioedema attacks, announced the promotion of Annick Deschoolmeester to Chief Human Resources Officer.

Immuneering Corporation announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for IMM-1-104, paving the way for the company to initiate a Phase 1/2a clinical trial of this oral, once daily small molecule, in development for the treatment of advanced RAS mutant solid tumors.

e-therapeutics plc is pleased to announce a fundraise of £13.5 million before expenses by way of a subscription for new ordinary shares of 0.1p each (“Ordinary Shares”) in the Company (the “Subscription”) at a price of 20p per Ordinary Share by funds managed by M&G Investment Management Limited (“M&G”), an institutional investor and an existing shareholder of the Company.

PT Bio Farma , the holding company for state-owned pharmaceutical companies in Indonesia , is ready to produce 20 million doses of the IndoVac COVID-19 vaccine this year and 100 million doses by 2024.

Ainos today announced the results from its antiviral efficacy study in hamsters against the Omicron variant of SARS-CoV-2 (the “Study”).

Accuray Incorporated (NASDAQ: ARAY) announced today the company is expanding its global footprint with the introduction of its CyberKnife ® platform in Africa.

Oragenics, Inc., a biotech company dedicated to fighting infectious diseases including coronaviruses, issued the following letter to shareholders from its President and Chief Executive Officer, Kim Murphy.

Eyenovia, Inc. today announced the planned retirement of lead independent director, Ken Lee, Jr., effective today, September 30, 2022.

EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing.